RBP Quaking (QKI) is involved in the treatment of NAFLD by modulating the PPARα expression, activating the transcription factor forkhead box protein O1 (FoxO1), and inhibiting triacylglycerol synthesis [30]. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.